Dr. Homayoon Shahidi, MD

Dr. Shahidi practices at Adventist Health Sonora in Sonora, California, part of Adventist Health.

Dr. Shahidi's NPI, 1295756419, was assigned on July 22, 2006. Dr. Shahidi graduated from Hacettepe University FOM in 1989. Dr. Shahidi holds California license C53428.

Dr. Shahidi's primary practice is Adventist Health Sonora, at 1000 Greenley Road, Sonora, CA 95370 in Tuolumne County. The practice phone is (209) 536-5000.

Dr. Shahidi's primary practice is Adventist Health Sonora in Sonora, California, part of Adventist Health. Dr. Shahidi is also affiliated with Dignity Health - Mark Twain Medical Center. The medical group on file is Adventist Health Sonora. Dmand AI also links Dr. Shahidi to 1 more home health agency and 1 medical group, each named with a free account. Dr. Shahidi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahidi practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shahidi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shahidi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Shahidi's licenses on file in 6 states: California, Minnesota, Nevada, North Dakota, Illinois and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and lung cancer among the conditions Dr. Shahidi treats.

CMS data shows 334 Medicare services from Dr. Shahidi across 4 procedure codes in 2024, all of them office visits, for 240 Medicare patients. Medicare paid $29,075 for them.

CMS counts 240 Medicare patients who saw Dr. Shahidi in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shahidi's median patient age at 76, with 47% women.

In 2024, Dr. Shahidi wrote 294 Medicare Part D claims for 96 patients. 76% of them were for generic drugs. CMS names the drug for 135 of them, across 8 drugs with 11 or more claims each, at $39,054 in total drug cost. In 2023, CMS named 546 claims across 22 drugs.

Dr. Shahidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shahidi as offering telehealth.

Dmand AI links 7 papers to Dr. Shahidi in 2006. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Leukemia, Lymphocytic, Chronic, B-Cell. Dr. Shahidi's most frequent co-authors are Stephanie Gregory, MD, James R. Jett, MD and William T. Leslie, MD.

CMS Open Payments shows 266 general payments to Dr. Shahidi from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Novartis Pharmaceuticals Corporation paid the most, $640.

Dmand AI lists 1 award for Dr. Shahidi, most recently CMS Stage 1 EHR in 2013.

Dr. Shahidi graduated from Hacettepe University FOM in 1989.

Dr. Shahidi is in network with 14 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.